TPST Tempest Therapeutics, Inc.
Fundamentals / CIK 0001544227 / USDTempest Therapeutics, Inc. reported $8.76M in total assets and a net loss of $40.59M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TPST in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$39.87M Operating profit
-
Net Income FY 2025-$40.59M GAAP bottom line
-
Diluted EPS FY 2025-$2.40 Split-adjusted
-
Free Cash Flow FY 2025-$26.82M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$897K Total debt: $7.26M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- | -- | $295K | $653K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | $790K | $5.40M |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | -$495K | -$4.75M |
| Research & Development | $12.61M | $28.48M | $17.50M | $22.53M | $17.17M | $14.39M | $27.84M | $14.43M | $18.34M | $21.64M |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | -- | -- | $27.74M | $49.22M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | $50.90M | $81.67M |
| Operating Income | -$26.57M | -$42.03M | -$29.16M | -$34.64M | -$26.99M | -$19.30M | -$45.40M | -$26.87M | -$84.33M | -$81.01M |
| EBITDA | -$26.31M | -$41.64M | -$28.78M | -$34.00M | -$26.61M | -$18.96M | -$45.30M | -$26.84M | -$82.68M | -$78.77M |
| Interest Expense | $207K | $1.32M | $1.45M | $1.62M | $1.28M | $0 | -- | $134K | $288K | -- |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -- | -$50.91M | -$82.06M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- | $67K | $201K |
| Net Income | -$26.26M | -$41.84M | -$29.49M | -$35.71M | -$28.30M | -$19.21M | -$44.57M | -$27.19M | -$84.58M | -$82.26M |
| Basic EPS | -$6.33 | -$19.50 | -$24.84 | -$40.18 | -$97.14 | -$533.55 | -$42.26 | -$228.61 | -$4,184.79 | -$33.29 |
| Diluted EPS | -$6.33 | -$19.50 | -$24.84 | -$40.18 | -$97.14 | -$533.55 | -$42.26 | -$228.61 | -$4,184.79 | -$33.29 |
| Basic Shares Outstanding | 4.1M | 2.1M | 1.2M | 888.1K | 291.5K | 36.0K | 1.1M | 119.0K | 20.2K | 2.5M |
| Diluted Shares Outstanding | 4.1M | 2.1M | 1.2M | 888.1K | 291.5K | 36.0K | 1.1M | 119.0K | 20.2K | 2.5M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $207K | $1.82M | $114K | $539K | $570K | $3.87M | $7.63M | $10.74M |
| Operating Income | -$2.82M | -$5.25M | -$27.72M | -$4.08M | -$3.60M | -$7.97M | -$10.94M | -$13.92M |
| EBITDA | -$2.77M | -$5.19M | -$27.66M | -$4.01M | -$3.53M | -$7.90M | -$10.87M | -$13.87M |
| Interest Expense | -- | $0 | $0 | $0 | $0 | $46K | $161K | $247K |
| Income Tax Expense | -- | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3.63M | -$5.24M | -$27.70M | -$4.02M | -$3.51M | -$7.87M | -$10.86M | -$13.81M |
| Basic EPS | -$0.21 | -$0.34 | -$2.53 | -- | -$0.79 | -$2.07 | -$3.16 | -- |
| Diluted EPS | -$0.21 | -$0.34 | -$2.53 | -- | -$0.79 | -$2.07 | -$3.16 | -- |
| Basic Shares Outstanding | 16.9M | 15.2M | 10.9M | -- | 4.4M | 3.8M | 3.4M | -- |
| Diluted Shares Outstanding | 16.9M | 15.2M | 10.9M | -- | 4.4M | 3.8M | 3.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7.71M | $30.27M | $39.23M | $31.23M | $51.83M | $18.82M | $62.48M | $73.29M | $17.58M | $43.93M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 | $51.50M | $70.46M |
| Cash & Short-Term Investments | $7.71M | $30.27M | $39.23M | $31.23M | $51.83M | $38.70M | $63.50M | $77.70M | $67.20M | $114.4M |
| Other Current Assets | $355K | $535K | $96K | $263K | $553K | $59K | -- | -- | -- | -- |
| Total Current Assets | $8.27M | $31.47M | $40.36M | $32.95M | $68.96M | $19.82M | $71.13M | $83.42M | $19.74M | $116.4M |
| Property, Plant & Equipment, Net | $605K | $886K | $840K | $1.06M | $1.11M | $1.11M | -- | -- | $3.11M | $5.57M |
| Other Non-Current Assets | $517K | $485K | $448K | $429K | $111K | $51K | $507K | $213K | $74K | $23K |
| Total Non-Current Assets | $8.66M | $10.01M | $11.24M | $13.14M | $4.28M | $3.04M | $3.84M | $652K | $74K | $6.10M |
| Total Assets | $16.93M | $41.49M | $51.60M | $46.09M | $73.24M | $22.86M | $74.97M | $84.07M | $19.81M | $122.5M |
| Accounts Payable | $1.04M | $2.45M | $845K | $1.11M | $991K | $1.07M | $1.50M | $2.00M | $1.30M | $2.18M |
| Short-Term Debt | $0 | $6.35M | $4.29M | -- | -- | $239K | $208K | $189K | $174K | -- |
| Total Current Liabilities | $3.31M | $14.22M | $9.41M | $7.28M | $20.03M | $3.22M | $12.52M | $9.82M | $4.09M | $13.21M |
| Long-Term Debt | -- | $0 | $6.26M | $10.37M | $15.07M | $0 | $168K | $383K | $599K | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $0 | $16K | $752K | $751K | $1.12M |
| Total Non-Current Liabilities | $6.95M | $8.14M | $15.42M | $20.70M | $17.09M | $1.73M | $2.58M | $1.14M | $738K | $1.12M |
| Total Liabilities | $10.26M | $22.36M | $24.84M | $27.98M | $37.12M | $4.95M | $15.10M | $10.95M | $4.83M | $14.32M |
| Total Debt (incl. Leases) | $8.14M | $15.37M | $20.66M | $22.11M | $18.54M | $2.61M | $4.52M | $572K | $773K | -- |
| Common Stock | $5.0K | $3.0K | $22K | $11K | $7.0K | $1.0K | $18K | $13K | $36K | $36K |
| Retained Earnings | -$233.4M | -$207.1M | -$165.3M | -$135.8M | -$100.1M | -$71.76M | -$208.7M | -$164.1M | -$136.9M | -$250.2M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | $452K | $165K | $148K | $8.0K | -$60K |
| Total Stockholders' Equity | $6.67M | $19.13M | $26.77M | $18.11M | $36.12M | -$68.79M | -$50.36M | $70.95M | -$130.7M | $108.2M |
| Total Equity | $6.67M | $19.13M | $26.77M | $18.11M | $36.12M | -$68.79M | $59.87M | $73.12M | -$128.5M | -$51.20M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $897K | $779K | $1.80M | $7.71M | $7.51M | $14.28M | $21.51M | $30.27M |
| Cash & Short-Term Investments | $897K | $779K | $1.80M | $7.71M | $7.51M | $14.28M | $21.51M | $30.27M |
| Other Current Assets | $417K | $417K | $3.0K | $355K | $352K | $482K | $356K | $535K |
| Total Current Assets | $1.61M | $1.70M | $2.45M | $8.27M | $8.10M | $15.10M | $22.43M | $31.47M |
| Property, Plant & Equipment, Net | $429K | $486K | $545K | $605K | $681K | $748K | $817K | $886K |
| Other Non-Current Assets | $81K | $501K | $509K | $517K | $519K | $529K | $538K | $485K |
| Total Non-Current Assets | $7.15M | $7.94M | $8.30M | $8.66M | $9.03M | $9.38M | $9.73M | $10.01M |
| Total Assets | $8.76M | $9.63M | $10.75M | $16.93M | $17.13M | $24.48M | $32.16M | $41.49M |
| Accounts Payable | $2.03M | $2.00M | $585K | $1.04M | $922K | $4.72M | $2.19M | $2.45M |
| Short-Term Debt | -- | -- | -- | $0 | $0 | $0 | $4.19M | $6.35M |
| Total Current Liabilities | $4.67M | $4.45M | $3.31M | $3.31M | $3.52M | $7.14M | $13.18M | $14.22M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $10K | $0 |
| Total Non-Current Liabilities | $5.92M | $6.27M | $6.62M | $6.95M | $7.26M | $7.56M | $7.85M | $8.14M |
| Total Liabilities | $10.59M | $10.72M | $9.93M | $10.26M | $10.78M | $14.70M | $21.03M | $22.36M |
| Total Debt (incl. Leases) | $7.26M | $7.56M | $7.85M | $8.14M | $8.40M | $8.66M | $13.12M | $15.37M |
| Common Stock | $17K | $16K | $14K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K |
| Retained Earnings | -$278.9M | -$275.3M | -$270.1M | -$233.4M | -$229.3M | -$225.8M | -$218.0M | -$207.1M |
| Total Stockholders' Equity | -$1.83M | -$1.09M | $822K | $6.67M | $6.35M | $9.78M | $11.13M | $19.13M |
| Total Equity | -$1.83M | -$1.09M | $822K | $6.67M | $6.35M | $9.78M | $11.13M | $19.13M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$26.26M | -$41.84M | -$29.49M | -$35.71M | -$28.30M | -$19.21M | -$44.57M | -$27.18M | -$84.59M | -$82.26M |
| Depreciation & Amortization | $266K | $389K | $381K | $638K | $374K | $339K | $97K | $32K | $1.65M | $2.24M |
| Stock-Based Compensation | $3.12M | $5.30M | $2.55M | $1.56M | $1.10M | $453K | $4.32M | $1.43M | $6.89M | $9.21M |
| Change in Payables | -$1.41M | $1.60M | -$263K | $1.0K | -$209K | -$574K | -$469K | $320K | $68K | -$1.18M |
| Operating Cash Flow | -$26.82M | -$33.03M | -$27.36M | -$31.07M | -$25.96M | -$19.02M | -$41.22M | -$23.65M | -$20.34M | -$61.73M |
| Capital Expenditure | $0 | -$435K | -$170K | -$562K | -$135K | -$50K | -$397K | -$36K | -$4.0K | -$2.59M |
| Free Cash Flow | -$26.82M | -$33.46M | -$27.53M | -$31.63M | -$26.09M | -$19.07M | -$41.62M | -$23.68M | -$20.34M | -$64.32M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | $0 | -$524K | $462K | -- |
| Investing Cash Flow | $0 | -$435K | -$170K | -$562K | -$97K | -$6.0K | $3.99M | $1.93M | $458K | $8.29M |
| Common Stock Issued | $6.04M | $28.59M | $35.60M | $8.86M | $33.42M | $0 | $26.69M | $0 | $0 | $53.92M |
| Financing Cash Flow | $4.26M | $24.50M | $35.60M | $11.40M | $59.06M | $34.60M | $26.94M | $77.74M | -$4.46M | $54.15M |
| Net Change in Cash | -$22.56M | -$8.96M | $8.07M | -$20.23M | $33.01M | -$24.85M | -$10.26M | $56.15M | -$24.33M | -- |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.63M | -$5.24M | -$27.70M | -$4.02M | -$3.51M | -$7.87M | -$10.86M | -$13.81M |
| Depreciation & Amortization | $57K | $59K | $60K | $65K | $66K | $67K | $68K | $49K |
| Stock-Based Compensation | -$54K | -$117K | $226K | $576K | $61K | $1.09M | $1.39M | $1.33M |
| Change in Payables | $36K | $1.41M | -$454K | $116K | -$3.79M | $2.53M | -$263K | $753K |
| Operating Cash Flow | -$2.05M | -$2.78M | -$7.60M | -$3.57M | -$6.78M | -$8.43M | -$8.04M | -$10.15M |
| Capital Expenditure | -- | $0 | $0 | $0 | $0 | $0 | $0 | -$3.0K |
| Free Cash Flow | -- | -$2.78M | -$7.60M | -$3.57M | -$6.78M | -$8.43M | -$8.04M | -$10.15M |
| Investing Cash Flow | -- | $0 | $0 | $0 | $0 | $0 | $0 | -$3.0K |
| Common Stock Issued | -- | -- | -- | $1.03M | $0 | $3.57M | $1.44M | $20.15M |
| Financing Cash Flow | $2.17M | $1.75M | $1.70M | $3.77M | $13K | $1.20M | -$721K | $17.95M |
| Net Change in Cash | $118K | -$1.03M | -$5.90M | $193K | -$6.77M | -$7.23M | -$8.76M | $7.80M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | -- | -- | -167.8% | -727.1% |
| Operating Margin | -- | -- | -- | -- | -- | -- | -- | -- | -28585.1% | -12406.1% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -- | -- | -28670.5% | -12597.2% |
| Return on Equity (ROE) | -393.9% | -218.8% | -110.2% | -197.2% | -78.4% | -- | -- | -38.3% | -- | -76.0% |
| Return on Assets (ROA) | -155.1% | -100.9% | -57.1% | -77.5% | -38.6% | -84.0% | -59.4% | -32.3% | -426.9% | -67.1% |
| Current Ratio | 2.50x | 2.21x | 4.29x | 4.53x | 3.44x | 6.15x | 5.68x | 8.50x | 4.82x | 8.82x |
| Quick Ratio | 2.33x | 2.13x | 4.17x | 4.29x | 2.59x | 12.01x | 5.07x | 7.91x | 16.43x | 8.66x |
| Debt to Equity | 1.22x | 0.80x | 0.77x | 1.22x | 0.51x | -- | -- | 0.01x | -- | -- |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -54.8% | +135.7% |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -5243.1% | -393.9% | -568.1% | -440.5% | -402.4% | -218.8% |
| Return on Assets (ROA) | -463.3% | -420.1% | -401.0% | -155.1% | -210.5% | -176.0% | -139.3% | -100.9% |
| Current Ratio | 0.34x | 0.38x | 0.74x | 2.50x | 2.30x | 2.11x | 1.70x | 2.21x |
| Quick Ratio | 0.19x | 0.18x | 0.55x | 2.33x | 2.13x | 2.00x | 1.63x | 2.13x |
| Debt to Equity | -- | -- | 9.55x | 1.22x | 1.32x | 0.89x | 1.18x | 0.80x |